The Market
Commercial litigation finance covers contract, business tort, antitrust, breach of fiduciary duty, and other business-versus-business claims, typically pursued by companies or their law firms against a well-capitalized counterparty. As a regulated outcomes market it looks structurally different from consumer-facing litigation finance: claim values are large, plaintiffs are often sophisticated repeat litigants rather than individuals, and the funding decision is frequently a corporate finance decision rather than a personal one, weighed against a company's own balance sheet capacity and its alternative cost of capital.
Outcome uncertainty in commercial cases is driven heavily by dispositive motion risk, since a large share of commercial claims resolve or narrow substantially at summary judgment before ever reaching a jury, which makes procedural-stage-specific probability modeling more important here than in most other verticals.
Because the plaintiff in a commercial matter is frequently a company evaluating funding as one financing option among several, the relevant comparison is not simply whether to fund a case but whether litigation finance is cheaper than the alternative sources of capital available to that company, including its own credit facilities. That comparison changes the sales motion and the pricing discipline required relative to a market where the plaintiff has no other source of capital at all.
Counterparties
Corporate plaintiffs and their general counsel, the law firms litigating on contingency or hybrid fee arrangements, commercial litigation funders providing case financing or portfolio facilities, defendants and their insurers or indemnifying parties, and increasingly the capital markets participants who provide the funders themselves with warehouse and fund-level capital. Because plaintiffs in this market are companies rather than individuals, the funding relationship is negotiated at arm's length between sophisticated parties, and disclosure and control-separation obligations are correspondingly more heavily negotiated.
General counsel evaluating a funding arrangement is also, in practice, evaluating a counterparty relationship that may recur, since a company with an active commercial litigation docket can be a repeat funding client across multiple matters over time. That repeat-relationship dynamic rewards funders who can demonstrate consistent, model-driven underwriting rather than case-by-case discretion, since a corporate counterparty comparing outcomes across several funded matters will notice inconsistency quickly.
What Decides Outcome, Duration, and Settlement
The controlling questions are the probability of surviving dispositive motions, the expected value of the claim conditional on reaching trial versus settling pre-trial, the duration to each of those procedural milestones by venue and judge, and the defendant's capacity and incentive to settle given its own litigation budget and reputational exposure. Judge-level and venue-level base rates matter more in commercial litigation than in almost any other vertical, because commercial dockets are smaller and individual judges' rulings on dispositive motions have an outsized effect on the outcome distribution.
Appellate risk is also more material in this vertical than in most others on this page, since a commercial judgment of significant size is more likely to be appealed than a personal injury verdict of comparable relative size, and the duration and value bands underwriting must account for should extend through a realistic probability of appeal rather than stopping at trial verdict.
How Criterica Serves This Market
Criterica Intelligence provides procedural-stage outcome modeling, judge- and venue-level base rates, and duration bands from filing through each major motion and trial milestone, purpose-built for the dispositive-motion-heavy posture of commercial claims. Criterica Capital deploys commercial litigation finance and portfolio facilities priced against that stage-specific intelligence rather than a single blended probability. Criterica Group governs the boundary between capital and control that commercial counterparties negotiate hardest over: the standard's separation-of-capital-and-legal-control principle is the explicit answer to sophisticated commercial counterparties' most common diligence question, which is whether the funder can influence litigation strategy or settlement authority.
Appellate-stage duration and outcome bands are modeled as a distinct phase rather than folded into a single pre-trial estimate, consistent with how sophisticated corporate counterparties themselves budget for litigation risk internally.
Data: What Exists, What Does Not
Federal and state commercial dockets, judge assignment histories, and motion-ruling records form a strong public data base for this market. What is scarcer is verified, non-public data on actual settlement values, since commercial settlements are confidential far more often than personal injury or mass tort resolutions, which makes settlement-value modeling in this vertical more dependent on structural inference from procedural posture than on direct comparable-settlement data.
Litigation funding disclosure itself remains inconsistent across jurisdictions in commercial matters, which is precisely the gap that proposed federal disclosure legislation has targeted, and which makes an auditable, standard-based governance posture a genuine differentiator for a funder operating in this vertical rather than a compliance afterthought.
Docket-level data on which judges grant versus deny dispositive motions at what rate is available but rarely assembled into a usable base rate, since it requires aggregating rulings across a large number of individual case files rather than reading any single opinion, which is exactly the kind of structured aggregation a court-record corpus is built to perform at scale.
Discuss Commercial Litigation
Capital partners, law firms, insurers, and institutional buyers evaluating this market.